Reducing Costs and Time of Cancer Trials

Outsourcing-pharma.com reports that a non-profit group made up of CEOs of drugmakers working in oncology hopes to shorten the drug testing process by making a “common language” available for clinical trial contracts through a set of standardized templates.

It is speculated that this procedure can cut contract negotiation times from 300 days to 30 days. This is coming at a crucial time in the pharma industry since the number of oncology clinical trials rose by 13 percent last year. The templates were part of a 14-month project which was led by the CEO Roundtable on Cancer's Life Sciences Consortium (LSC), a task force of CEO Roundtable members in the oncology pharmaceutical/biotechnology industries in conjunction with the NCI.